BackIndo US Bio-Tech Limited Overview

Indo US Bio-Tech Limited Receivables

Indo US Bio-Tech Limited's receivables is $360M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$363.12M
↓ 19.88% YoYΔ $-90.09M vs prior year quarter

Peer trimmed avg / median

Loading

Indo US Bio-Tech Limited Receivables History

Loading

Indo US Bio-Tech Limited vs. peers: Receivables Comparison

Loading

Indo US Bio-Tech Limited Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Indo US Bio-Tech Limited (INDOUS.BO) FAQ

Indo US Bio-Tech Limited (INDOUS.BO) currently reports a receivables of $360M as of September 2026. That compares with $450M in the prior-year period — down 19.9% year over year. Use the charts on this page to explore Indo US Bio-Tech Limited's receivables history and peer comparisons.

Indo US Bio-Tech Limited's receivables decreased from $450M to $360M — a 19.9% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Indo US Bio-Tech Limited reported $360M in receivables as of September 2026. That compares with $450M in the prior-year period — down 19.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $360M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Indo US Bio-Tech Limited, and consider following INDOUS.BO for alerts when major investors trade the stock.

Questions & Answers